Cargando…
Predominance of the heterozygous CCR5 delta‐24 deletion in African individuals resistant to HIV infection might be related to a defect in CCR5 addressing at the cell surface
INTRODUCTION: The chemokine receptor CCR5 is the main co‐receptor for R5‐tropic HIV‐1 variants. We have previously described a novel 24‐base pair deletion in the coding region of CCR5 among individuals from Rwanda. Here, we investigated the prevalence of hCCR5Δ24 in different cohorts and its impact...
Autores principales: | Arendt, Vic, Amand, Mathieu, Iserentant, Gilles, Lemaire, Morgane, Masquelier, Cécile, Ndayisaba, Gilles F, Verhofstede, Chris, Karita, Etienne, Allen, Susan, Chevigné, Andy, Schmit, Jean‐Claude, Bercoff, Danielle Perez, Seguin‐Devaux, Carole |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6727025/ https://www.ncbi.nlm.nih.gov/pubmed/31486251 http://dx.doi.org/10.1002/jia2.25384 |
Ejemplares similares
-
The Envelope Cytoplasmic Tail of HIV-1 Subtype C Contributes to Poor Replication Capacity through Low Viral Infectivity and Cell-to-Cell Transmission
por: Santos da Silva, Eveline, et al.
Publicado: (2016) -
Why CCR2 and CCR5 Blockade Failed and Why CCR1 Blockade Might Still Be Effective in the Treatment of Rheumatoid Arthritis
por: Lebre, Maria C., et al.
Publicado: (2011) -
HEK293T Cells Are Heterozygous for CCR5 Delta 32 Mutation
por: Qi, Chunxia, et al.
Publicado: (2016) -
Cenicriviroc, a Novel CCR5 (R5) and CCR2 Antagonist, Shows In Vitro Activity against R5 Tropic HIV-2 Clinical Isolates
por: Visseaux, Benoit, et al.
Publicado: (2015) -
CC Chemokines in a Tumor: A Review of Pro-Cancer and Anti-Cancer Properties of Receptors CCR5, CCR6, CCR7, CCR8, CCR9, and CCR10 Ligands
por: Korbecki, Jan, et al.
Publicado: (2020)